|
|
| | [2H8]-Oxcarbazepine Basic information |
| Product Name: | [2H8]-Oxcarbazepine | | Synonyms: | [2H8]-Oxcarbazepine;Oxcarbazepine D7 major;Oxcarbazepine-[d8];10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-1,2,3,4,7,8,9-d7-5-carboxamide[b,f]azepine-1,2,;D8-Oxcarbazepine;Oxcarbazepine-[D8] (Standard) | | CAS: | 1261396-65-9 | | MF: | C15H12N2O2 | | MW: | 252.27 | | EINECS: | | | Product Categories: | | | Mol File: | 1261396-65-9.mol | ![[2H8]-Oxcarbazepine Structure](CAS/20211123/GIF/1261396-65-9.gif) |
| | [2H8]-Oxcarbazepine Chemical Properties |
| | [2H8]-Oxcarbazepine Usage And Synthesis |
| Uses | Oxcarbazepine-d8-1 is a deuterium of Oxcarbazepine. Oxcarbazepine is a sodium channel blocker[1]. Oxcarbazepine significantly inhibits glioblastoma cell growth and induces apoptosis or G2/M arrest in glioblastoma cell lines[2]. Oxcarbazepine-d8-1 has anti-cancer and anticonvulsant effects[2]. | | References | [1] Ashley M Thomas, et al. Old Friends With New Faces: Are Sodium Channel Blockers the Future of Adjunct Pain Medication ManagementJ Pain. 2018 Jan;19(1):1-9. DOI:10.1016/j.jpain.2017.08.001
[2] Ching-Yi Lee,et al. The effects of antiepileptic drugs on the growth of glioblastoma cell lines. J Neurooncol. 2016 May;127(3):445-53. DOI:10.1007/s11060-016-2056-6 |
| | [2H8]-Oxcarbazepine Preparation Products And Raw materials |
|